# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | ALA3233822 | 5c | t1/2 | = | 8 | min | ALA3238624 | hr | Mus musculus | |||
2. | ALA3233822 | 5c | Stability | = | 30 | % | ALA3238623 | % | Mus musculus | |||
3. | ALA3233822 | 5c | CC50 | > | 100 | uM | ALA3238622 | nM | Homo sapiens | |||
4. | ALA3233822 | 5c | Ratio CC50/EC50 | > | 10.5 | ALA3238621 | ||||||
5. | ALA3233822 | 5c | CC50 | > | 100 | uM | ALA3238620 | nM | ||||
6. | ALA3233822 | 5c | EC50 | = | 9.5 | uM | ALA3238619 | 5.02 | nM | Severe acute respiratory syndrome-related coronavirus | ||
7. | ALA3233822 | 5c | INH | > | 30 | % | ALA3238618 | % | Human coronavirus NL63 | |||
8. | ALA3233822 | 5c | Imax | = | 67 | % | ALA3239942 | % | Human coronavirus NL63 | |||
9. | ALA3233822 | 5c | IC50 | = | 59 | uM | ALA3239942 | 4.23 | nM | Human coronavirus NL63 | ||
10. | ALA3233822 | 5c | IC50 | = | 0.35 | uM | ALA3239923 | 6.46 | nM | |||
11. | ALA3233822 | 5c | IC50 | = | 0.35 | uM | ALA3239922 | 6.46 | nM | |||
12. | ALA3233822 | 5c | IC50 | = | 0.35 | uM | ALA3239921 | 6.46 | nM | |||
13. | ALA3233822 | 5c | Imax | = | 100 | % | ALA3239920 | % | ||||
14. | ALA3233822 | 5c | IC50 | = | 0.35 | uM | ALA3239920 | 6.46 | nM | |||
15. | ALA3233822 | 5c | INH | 0 | ALA3238625 | Active | % | |||||
16. | ALA3233822 | 5c | IC50 | = | 1.85 | uM | ALA5109240 | 5.73 | nM | Severe acute respiratory syndrome coronavirus 2 | ||
17. | ALA3233822 | 5c | IC50 | = | 4.32 | uM | ALA5109239 | 5.37 | nM | Severe acute respiratory syndrome coronavirus 2 |